Janux Therapeutics, Inc. (JANX) SEC Filings — 2025
7 SEC filings for Janux Therapeutics, Inc. (JANX) in 2025.
Filings
- Janux R&D Soars, Net Loss Widens to $81.7M Amid Revenue Dip — 10-Q · Nov 6, 2025
- Janux Therapeutics Announces Board and Compensation Changes — 8-K · Sep 19, 2025
- Janux's Q2 Loss Widens Amid R&D Surge; Merck Deal Offers Future Upside — 10-Q · Aug 7, 2025
- Janux Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jun 13, 2025
- Janux Therapeutics Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Janux Therapeutics DEF 14A: Executive Compensation Details — DEF 14A · Apr 25, 2025
- Janux Therapeutics, Inc. 10-K Filing — 10-K · Feb 27, 2025